This year we returned to etc.venues in London for our 14th BioTrinity, a fantastic event attended by over 700 of life science’s top investors, scientific entrepreneurs, business leaders and more. From the start, there was a definite buzz that we have all been missing. Everybody was happy to be back, meeting up with old colleagues and partners, and making new connections. 

The two conference tracks on Business and Science were packed, often with standing room only, as attendees joined to hear the latest developments and new trends. And the networking was non-stop from breakfast to dinner, with over 1500 partner meetings during the event.

The Business and Science tracks were both packed with great speakers and discussions. Over the two days, the Science track touched on the latest developments in Oncology; Rare, Inflammatory and Infectious Diseases; Microbiome and CNS; as well as AI, Data and Platforms which are key across all areas.

In the Business track we had insights into how the UK government’s vision will impact your business from George Freeman, MP as well as some great interviews and panel discussions on topics such as: global capital markets, clinical trial design strategies and investment trends.

We want to thank everyone for making BioTrinity 2022 a great success, whether you were a visitor, exhibitor or speaker, but particularly our sponsors.

A special thank you to our Gold Sponsors: Fujifilm Diosynth Biotechnologies, Hays Specialist Recruitment, Lonza, MEPC Milton Park, Oxford North, Precision for Medicine, Sanofi and ThermoFisher Scentific.

You can see the full list of sponsors below:

We are pleased to announce that BioTrinity 2023 will be taking place once again in London on Tuesday 25 and Wednesday 26 April – venue to be announced!

Keep up-to-date on all of the latest OBN News and events at www.obn.org.uk, and if you’d like to be added to our mailing list, please email: colin.oneill@obn.org.uk

Best wishes